FDA Nominee Addresses Vaccine Safety During Senate Hearing

Why it matters locally: Federal oversight of vaccine safety and childhood immunization initiatives by the FDA directly impacts public health guidelines and vaccine access for Connecticut residents, as well as the operations of healthcare providers and pharmaceutical distributors within the state.

---

WASHINGTON – Heidi Overton, President Donald Trump's nominee to lead the Food and Drug Administration (FDA), spoke to senators Thursday during her confirmation hearing. Overton addressed the safety of long-established vaccines. Senators questioned Overton on the White House's initiatives regarding childhood immunizations. Her testimony followed President Trump's nomination for the FDA's top role.